| Analysis of anticancer drugs: a review S Nussbaumer, P Bonnabry, JL Veuthey, S Fleury-Souverain Talanta 85 (5), 2265-2289, 2011 | 689 | 2011 |
| Successful implementation of the World Health Organization hand hygiene improvement strategy in a referral hospital in Mali, Africa B Allegranzi, H Sax, L Bengaly, H Riebet, DK Minta, MN Chraiti, ... Infection Control & Hospital Epidemiology 31 (2), 133-141, 2010 | 272 | 2010 |
| Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile N Vernaz, H Sax, D Pittet, P Bonnabry, J Schrenzel, S Harbarth Journal of Antimicrobial Chemotherapy 62 (3), 601-607, 2008 | 198 | 2008 |
| Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions P Bonnabry, L Cingria, F Sadeghipour, H Ing, C Fonzo-Christe, RE Pfister BMJ Quality & Safety 14 (2), 93-98, 2005 | 180 | 2005 |
| A risk analysis method to evaluate the impact of a computerized provider order entry system on patient safety P Bonnabry, C Despont-Gros, D Grauser, P Casez, M Despond, D Pugin, ... Journal of the American Medical Informatics Association 15 (4), 453-460, 2008 | 159 | 2008 |
| Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process P Bonnabry, L Cingria, M Ackermann, F Sadeghipour, L Bigler, N Mach International Journal for Quality in Health Care 18 (1), 9-16, 2006 | 151 | 2006 |
| Use of transdermal drug formulations in the elderly LZ Kaestli, AF Wasilewski-Rasca, P Bonnabry, N Vogt-Ferrier Drugs & aging 25, 269-280, 2008 | 132 | 2008 |
| A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs. TD Leemann, C Transon, P Bonnabry, P Dayer Drugs under experimental and clinical research 19 (5), 189-195, 1993 | 132 | 1993 |
| Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community N Vernaz, B Huttner, D Muscionico, JL Salomon, P Bonnabry, ... Journal of Antimicrobial Chemotherapy 66 (4), 928-935, 2011 | 119 | 2011 |
| Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review C Fonzo-Christe, C Vukasovic, AF Wasilewski-Rasca, P Bonnabry Palliative medicine 19 (3), 208-219, 2005 | 110 | 2005 |
| Drug-related problems identification in general internal medicine: the impact and role of the clinical pharmacist and pharmacologist B Guignard, P Bonnabry, A Perrier, P Dayer, J Desmeules, CF Samer European journal of internal medicine 26 (6), 399-406, 2015 | 107 | 2015 |
| Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality C StuCki, AAMAA SAutter, JC FAvet, P BonnABry American Journal of Health-System Pharmacy 66 (22), 2032-2036, 2009 | 107 | 2009 |
| Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicines RD Marini, E Rozet, MLA Montes, C Rohrbasser, S Roht, D Rhème, ... Journal of Pharmaceutical and Biomedical Analysis 53 (5), 1278-1287, 2010 | 102 | 2010 |
| Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam P Bonnabry, T Leemann, P Dayer European journal of clinical pharmacology 49, 305-308, 1996 | 92 | 1996 |
| Patented drug extension strategies on healthcare spending: a cost-evaluation analysis N Vernaz, G Haller, F Girardin, B Huttner, C Combescure, P Dayer, ... PLoS medicine 10 (6), e1001460, 2013 | 82 | 2013 |
| Compatibility of intravenous medications with parenteral nutrition: in vitro evaluation L Bouchoud, C Fonzo‐Christe, M Klingmüller, P Bonnabry Journal of Parenteral and Enteral Nutrition 37 (3), 416-424, 2013 | 82 | 2013 |
| Antineoplastic drugs and their analysis: a state of the art review N Guichard, D Guillarme, P Bonnabry, S Fleury-Souverain Analyst 142 (13), 2273-2321, 2017 | 77 | 2017 |
| Wipe sampling procedure coupled to LC–MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces S Nussbaumer, L Geiser, F Sadeghipour, D Hochstrasser, P Bonnabry, ... Analytical and bioanalytical chemistry 402, 2499-2509, 2012 | 73 | 2012 |
| Effectiveness of a closed-system transfer device in reducing surface contamination in a new antineoplastic drug-compounding unit: a prospective, controlled, parallel study N Simon, M Vasseur, M Pinturaud, M Soichot, C Richeval, L Humbert, ... PLoS One 11 (7), e0159052, 2016 | 70 | 2016 |
| Automation of in-hospital pharmacy dispensing: a systematic review S Batson, A Herranz, N Rohrbach, M Canobbio, SA Mitchell, P Bonnabry European Journal of Hospital Pharmacy 28 (2), 58-64, 2021 | 67 | 2021 |